New study finds Trump-touted hydroxychloroquine does not benefit coronavirus patients


A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
A nationwide study that's been submitted to the New England Journal of Medicine found that hydroxychloroquine — a malaria drug often touted by President Trump has a strong candidate for COVID-19 therapy — does not benefit coronavirus patients, The Associated Press reports.
In fact, the analysis, which tracked 368 patients in U.S. veterans hospitals, shows that patients treated with the drug actually died at a higher rate than those treated with standard care. Hydroxychloroquine reportedly also didn't make a difference when it comes to who needed a breathing machine.
The study was the largest to look at the drug so far, but like its predecessors, it still isn't considered a rigorous experiment and has yet to be peer-reviewed. The National Institutes of Health and other research labs are in the process of conducting large-scale trials that will hopefully paint a clear picture of its efficacy. Still, several scientists have been "underwhelmed" with the drug's performance so far. Read more at The Associated Press.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Rishi Sunak lambasts China after allegations of spy in UK Parliament
Speed Read
By Justin Klawans Published
-
Judge denies Mark Meadows' request to move Georgia case to federal court
Speed Read
By Justin Klawans Published
-
Former New Mexico governor Bill Richardson dies at 75
Speed Read
By Justin Klawans Published
-
Clarence Thomas officially discloses trips from billionaire GOP donor
Speed Read
By Justin Klawans Published
-
Judge schedules Trump federal election plot trial for crowded March 2024
Speed Read
By Peter Weber Published
-
Trump surrenders in Georgia election subversion case
Speed Read
By Catherine Garcia Published
-
Wagner chief Yevgeny Prigozhin, Putin ally-turned-rival, presumed dead in plane crash
Speed Read
By Peter Weber Published
-
Mar-a-Lago IT director flipped on Trump after dropping Trump-linked lawyer, special counsel says
Speed Read
By Peter Weber Published